Recombinant Human EG-VEGF/PK1 Protein

• Reactivity: Hu
• Applications: Bioactivity
• Concentration: LYOPH

Recombinant Human EG-VEGF/PK1 Protein Summary

• Description: A single non-glycosylated polypeptide chain containing 86 amino acids.
  
  

  Source: Escherichia coli.

  Amino Acid Sequence:
  AVITGACERD VQCGAGTCCA ISLWLRGLRM CTPLGREGEE CHPGSHKVPF FRKRKHHTCP CLPNLLCSRF PDGRYRCSMD LKNINF

• Details of Functionality: Fully biologically active when compared to standard. The ED50 as determined by a cell proliferation assay using bovine EJG cells is less than 2.0 ug/ml, corresponding to a specific activity of > 500 IU/mg.
• Source: E. coli
• Protein/Peptide Type: Recombinant Protein
• Gene: PROK1
• Purity: >98%, by HPLC
• Endotoxin Note: Less than 0.1 EU/ug of rHuEG-VEGF as determined by LAL method.

Applications/Dilutions

• Theoretical MW: 9.7 kDa.
  Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: Lyophilized from a 0.2 um filtered concentrated solution in PBS, pH 7.4, 0.02 % Tween-20.
• Preservative: No Preservative
• Concentration: LYOPH
• Purity: >98%, by HPLC
• Reconstitution Instructions: Reconstitute with sterilized distilled water or 0.1% BSA aqueous buffer to a final concentration of 0.1 - 1.0 mg/ml.

Alternate Names for Recombinant Human EG-VEGF/PK1 Protein

• EGVEGF
• EG-VEGF
• EGVEGFblack mamba toxin-related protein
• Endocrine-gland-derived vascular endothelial growth factor
• Mambakine
• PK1mambakine
• PRK1prokineticin-1
• PROK1
• Prokineticin 1

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: PROK1